58606244_e_of_Technology_Transfer__OTT___Title
[Subject Matter] Animal Health [Docket] 105.10 [Description] Vibrio vulnificus is a Gram-negative halophilic bacterium common to estuarine and marine environments. The bacterium receives much attention due to the ability to produce disease in humans (usually immunocompromised people) either by consumption of raw oysters and/or contact with the bacterium in the marine environment. The USDA isolated and characterized V. vulnificus from the sick fish. Biochemical analyses demonstrated that the isolate is a biotype 1 isolate and molecular characterization of the 16S rRNA demonstrated the isolate was 16S rRNA type B. This rRNA type is usually associated with clinical human cases. Following isolation and characterization, ARS developed an inactivated vaccine that is effective in preventing the disease in tilapia grown in low saline water (1.5 ppt). [Title] 
INACTIVATED VIBRIO VULNIFICUS VACCINE
ARS : Office of Technology Transfer (OTT)